发明授权
- 专利标题: Beta-lactamase inhibitors
-
申请号: US16238363申请日: 2019-01-02
-
公开(公告)号: US10669290B2公开(公告)日: 2020-06-02
- 发明人: Christopher J. Burns , Denis Daigle , Bin Liu , Daniel McGarry , Daniel C. Pevear , Robert E. Lee Trout
- 申请人: VenatoRx Pharmaceuticals, Inc.
- 申请人地址: US PA Malvern
- 专利权人: VENATORX PHARMACEUTICALS, INC.
- 当前专利权人: VENATORX PHARMACEUTICALS, INC.
- 当前专利权人地址: US PA Malvern
- 代理机构: Wilson Sonsini Goodrich & Rosati
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K45/06 ; A61K31/69 ; C07F5/04 ; C07F5/02
摘要:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
公开/授权文献
- US20190225628A1 BETA-LACTAMASE INHIBITORS 公开/授权日:2019-07-25
信息查询